Community
Ilana Glazer is ready to say goodbye to 'weak-minded' alt-right comedy
By Samantha R. Patel
GLP-1 drugs must now carry warning labels about rare risk of vision loss
Jasmine T. Winters
Jasmine T. Winters
Reporter · King of Prussia, PA
Jasmine is a recent graduate of the University of Pennsylvania and has quickly made a name for herself in local journalism covering community events for the King of Prussia Chronicle. With a keen interest in local history and cultural initiatives, she enjoys sharing stories that reflect the town’s rich heritage.
More from Jasmine →Reporter · Tuesday, November 10, 2026 at 9:28 PM · 1 min read
FDA is now requiring GLP-1 weight-loss drugs to include warning information about the rare potential for vision loss. The mandate follows a review of available research and patient complaints, but the FDA did not find a direct cause-and-effect relationship between GLP-1s and vision loss.
Up nextIlana Glazer is ready to say goodbye to 'weak-minded' alt-right comedyCommunity · 1 min read
